ENQUIRY
NeuroStar TMS Therapy®

NeuroStar TMS Therapy®

TMS1

How Does NeuroStar TMS Therapy® Work?

Transcranial magnetic stimulation (TMS) uses a targeted pulsed magnetic field, similar to what is used in an MRI (magnetic resonance imaging) machine. While the patient is awake and alert, NeuroStar TMS Therapy stimulates areas of the brain that are underactive in depression.2

NeuroStar TMS Therapy is an in-office treatment that takes 37 minutes, is performed while the patient sits in a chair, and is administered five days a week, for up to four to six weeks.

Simple steps for NeuroStar TMS Therapy:

  • Step One: The patient reclines comfortably in the treatment chair, awake and alert
  • Step Two: A small curved device containing the magnetic coil rests lightly on the patient’s head
  • Step Three: The device delivers focused magnetic stimulation directly to the target areas of the brain
  • Step Four: The patient can immediately resume normal activities

During treatment, the patient hears a clicking sound and feels a tapping sensation on the head. The most common side effect is generally mild-to-moderate pain or discomfort at or near the treatment area during the session. When this occurs it is temporary, and typically occurs only during the first week of treatment.

There are no effects on alertness or understanding; patients being treated with NeuroStar TMS Therapy can drive themselves to and from their treatment sessions. Above information is taken from: https://neurostar.com/neurostar-tms-depression-treatment/

For more information on the rTMS treatment, please go to http://www.tms-singapore.com/ or call us at +65 63977309.

 

3000 Pulses to Happiness?

3000 Pulses to Happiness?

TMS picture of Leeran on TMS

 

 

 

 

 

 

3000 Pulses to Happiness?… yes it is possible through TMS treatment!

Each of us has a different genetic make-up, which is why anti-depressants might be ineffective. Depression is a chronic mental illness that cannot be overcome by simple positive thinking. Many who suffer cannot lead a normal life and are often in isolation.

Promises Healthcare is the pioneer in providing rTMS treatment. rTMS stands for Repetitive Transcranial Magnetic Stimulation or repetitive magnetic brain stimulation (also called TMS). It is a non-drug alternative to anti-depressants and ECT without any of the side effects. The treatment requires 20-30 sessions lasting 40 minutes each. During each session 3000 magnetic pulses are delivered to the specific area of the brain that regulates moods.

For more information on the rTMS treatment, please go to http://www.tms-singapore.com/ or call us at +65 63977309.

Dr. Munidasa Winslow

Dr. Munidasa Winslow

about_winslowMBBS, M.Med.(Psych), CMAC, CCS, FAMS

Dr Winslow has worked in general psychiatry and addiction medicine at IMH since 1988. He was one of the pioneers responsible for the setting up and development of addiction services both in the hospital and in the community. His last appointment was as chief of the Addiction Medicine Department, IMH.

He has been a pioneer in addiction and impulse control disorders (alcohol, substance dependence, gambling, gaming, sexual compulsivity etc) in the Asia-Pacific region. He is a sought after speaker at addiction conferences around the region. Despite being a fully qualified psychiatrist, he has taken the time and effort to maintain and develop his therapy/counselling skills as seen by his being accredited as a certified master addiction counsellor and a certified clinical supervisor.

He has published and presented widely on both general psychological and addiction issues. He continues his academic and research interests through his academic appointments with NUHS and teaching in many counselling courses. His passion is to help therapists develop and hone their skills to effect real change in those they seek to help.

Dr Winslow is also the founder and executive director of Promises Pte Ltd, which is a mental health & addictions consulting and training company established to help healthcare professionals and individuals in Singapore.